Search Results - "GISKE, C. G."

Refine Results
  1. 1

    Global dissemination of extensively drug‐resistant carbapenemase‐producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control by Tängdén, T., Giske, C. G.

    Published in Journal of internal medicine (01-05-2015)
    “…The prevalence of carbapenem‐resistant Gram‐negative bacilli is on the rise worldwide, posing a major public health threat. Previously, this was mostly a…”
    Get full text
    Journal Article
  2. 2

    Invasive infection caused by Klebsiella pneumoniae is a disease affecting patients with high comorbidity and associated with high long-term mortality by Vading, M, Nauclér, P, Kalin, M, Giske, C G

    Published in PloS one (06-04-2018)
    “…Klebsiella pneumoniae (KP) is after Escherichia coli (EC) the most common gram-negative species causing invasive infections. Herein, we analyzed risk factors…”
    Get full text
    Journal Article
  3. 3

    Evaluation of Double- and Triple-Antibiotic Combinations for VIM- and NDM-Producing Klebsiella pneumoniae by In Vitro Time-Kill Experiments by TANGDEN, T, HICKMAN, R. A, FORSBERG, P, LAGERBÄCK, P, GISKE, C. G, CARS, O

    Published in Antimicrobial Agents and Chemotherapy (01-03-2014)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  4. 4

    Contemporary resistance trends and mechanisms for the old antibiotics colistin, temocillin, fosfomycin, mecillinam and nitrofurantoin by Giske, C.G.

    Published in Clinical microbiology and infection (01-10-2015)
    “…Recently there has been a renewed interest in reviving older antimicrobial agents, particularly those with activity against multidrug-resistant Gram-negative…”
    Get full text
    Journal Article
  5. 5

    Poor Correlation between Meropenem and Piperacillin Plasma Concentrations and Delivered Dose of Continuous Renal Replacement Therapy by Petersson, J, Giske, C G, Eliasson, E

    Published in Antimicrobial agents and chemotherapy (18-03-2021)
    “…There is insufficient data on the relationship between antibiotic dosing and plasma concentrations in patients treated with continuous renal replacement…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Escherichia coli: an old friend with new tidings by Vila, J., Sáez-López, E., Johnson, J. R., Römling, U., Dobrindt, U., Cantón, R., Giske, C. G., Naas, T., Carattoli, A., Martínez-Medina, M., Bosch, J., Retamar, P., Rodríguez-Baño, J., Baquero, F., Soto, S. M.

    Published in FEMS microbiology reviews (01-07-2016)
    “…Escherichia coli is one of the most-studied microorganisms worldwide but its characteristics are continually changing. Extraintestinal E. coli infections, such…”
    Get full text
    Journal Article
  9. 9

    Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paper by Turnidge, J., Kahlmeter, G., Cantón, R., MacGowan, A., Giske, C.G.

    Published in Clinical microbiology and infection (01-08-2020)
    “…This position paper describes the view adopted by EUCAST on the role of daptomycin in the treatment of serious infections caused by Enterococcus species…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe by Cantón, R., Akóva, M., Carmeli, Y., Giske, C.G., Glupczynski, Y., Gniadkowski, M., Livermore, D.M., Miriagou, V., Naas, T., Rossolini, G.M., Samuelsen, Ø., Seifert, H., Woodford, N., Nordmann, P.

    Published in Clinical microbiology and infection (01-05-2012)
    “…Plasmid-acquired carbapenemases in Enterobacteriaceae, which were first discovered in Europe in the 1990s, are now increasingly being identified at an alarming…”
    Get full text
    Journal Article
  12. 12

    Identification and screening of carbapenemase-producing Enterobacteriaceae by Nordmann, P., Gniadkowski, M., Giske, C.G., Poirel, L., Woodford, N., Miriagou, V.

    Published in Clinical microbiology and infection (01-05-2012)
    “…Carbapenem-hydrolysing β-lactamases are the most powerful β-lactamases, being able to hydrolyse almost all β-lactams. They are mostly of the KPC, VIM, IMP, NDM…”
    Get full text
    Journal Article
  13. 13

    EUCAST expert rules in antimicrobial susceptibility testing by Leclercq, R., Cantón, R., Brown, D.F.J., Giske, C.G., Heisig, P., MacGowan, A.P., Mouton, J.W., Nordmann, P., Rodloff, A.C., Rossolini, G.M., Soussy, C.-J., Steinbakk, M., Winstanley, T.G., Kahlmeter, G.

    Published in Clinical microbiology and infection (01-02-2013)
    “…EUCAST expert rules have been developed to assist clinical microbiologists and describe actions to be taken in response to specific antimicrobial…”
    Get full text
    Journal Article
  14. 14

    Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts by Grundmann, H, Livermore, D M, Giske, C G, Canton, R, Rossolini, G M, Campos, J, Vatopoulos, A, Gniadkowski, M, Toth, A, Pfeifer, Y, Jarlier, V, Carmeli, Y

    “…The emergence and global spread of carbapenemase-producing Enterobacteriaceae is of great concern to health services worldwide. These bacteria are often…”
    Get full text
    Journal Article
  15. 15

    Genomic analysis revealed distinct transmission clusters of vancomycin-resistant Enterococcus faecium ST80 in Stockholm, Sweden by Fang, H., Fröding, I., Ullberg, M., Giske, C.G.

    Published in The Journal of hospital infection (01-01-2021)
    “…Vancomycin-resistant Enterococcus faecium (VREfm) belonging to sequence type (ST)80 has become the predominant clonal lineage in Stockholm in the last three…”
    Get full text
    Journal Article
  16. 16

    Metagenomic analysis of bloodstream infections in patients with acute leukemia and therapy-induced neutropenia by Gyarmati, P., Kjellander, C., Aust, C., Song, Y., Öhrmalm, L., Giske, C. G.

    Published in Scientific reports (21-03-2016)
    “…Leukemic patients are often immunocompromised due to underlying conditions, comorbidities and the effects of chemotherapy and thus at risk for developing…”
    Get full text
    Journal Article
  17. 17

    Standard dosing of piperacillin and meropenem fail to achieve adequate plasma concentrations in ICU patients by Petersson, J., Giske, C. G., Eliasson, E.

    Published in Acta anaesthesiologica Scandinavica (01-11-2016)
    “…Background Controversies remain regarding optimal dosing and the need for plasma concentration measurements when treating intensive care patients with…”
    Get full text
    Journal Article
  18. 18

    Molecular characterization of VIM-producing Klebsiella pneumoniae from Scandinavia reveals genetic relatedness with international clonal complexes encoding transferable multidrug resistance by Samuelsen, Ø., Toleman, M.A., Hasseltvedt, V., Fuursted, K., Leegaard, T.M., Walsh, T.R., Sundsfjord, A., Giske, C.G.

    Published in Clinical microbiology and infection (01-12-2011)
    “…VIM-producing Klebsiella pneumoniae (VPKP) has been identified as a source of hospital outbreaks and is prevalent particularly in the Mediterranean region. In…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Frequent acquisition of low-virulence strains of ESBL-producing Escherichia coli in travellers by Vading, M, Kabir, M H, Kalin, M, Iversen, A, Wiklund, S, Nauclér, P, Giske, C G

    Published in Journal of antimicrobial chemotherapy (01-12-2016)
    “…International travel is a risk factor for intestinal colonization with ESBL-producing Enterobacteriaceae (EPE). This prospective cohort study focuses on…”
    Get full text
    Journal Article